- Release Date: 06/06/14 16:01
- Summary: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 8.24KB
FPH 06/06/2014 16:01 RELINT REL: 1601 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Directors and Officers Relevant Interests A Details of director or officer Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 May 2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 30 May 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 141,000 FPH options and issue of 34,088 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 11 September 2013 A Details of director or officer Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 May 2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 30 May 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 135,000 FPH options and issue of 17,755 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 11 September 2013 A Details of director or officer Name of director or officer of public issuer: Paul ANDREASSI Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Quality & Regulatory B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial interest Name of registered holder of securities Paul ANDREASSI D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 May 2014 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of cancellation: 30 May 2014 Consideration received for cancellation: NZ$Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: Cancellation of 75,000 FPH options and issue of 9,864 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 11 September 2013 A Details of director or officer Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 30 May 2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 30 May 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 135,000 FPH options and issue of 17,755 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 11 September 2013 A Details of director or officer Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) Ordinary shares and options to acquire ordinary shares ii) Ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: "30 May 2014 " Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation and sale: i) 30 May 2014; ii) 30 May 2014 Consideration received for cancellation and sale: i) $Nil; ii) $36,400 Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: "i) Cancellation of 95,000 FPH options and issue of 12,494 ordinary shares; ii) Sale of 8,000 ordinary shares" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 5 March 2014 A Details of director or officer Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "Ordinary shares and options to acquire ordinary shares " C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 3 June 2014 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 3 June 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: "Cancellation of 30,000 FPH options and issue of 5,237 ordinary shares " E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 11 September 2013 End CA:00251309 For:FPH Type:RELINT Time:2014-06-06 16:01:42
Ann: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
Add to My Watchlist
What is My Watchlist?
